Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Shockwave Medical launches new IVL catheter for challenging lesions in Europe
The balloon-free catheter, which already had a successful launch in the United States, has been associated with positive outcomes and the ability to reach certain lesions more accurately than balloon-based IVL platforms.
Multimodality imagers play a critical role in modern heart teams
Heart teams continue to play a major role at hospitals and health systems all over the world. Cardiac imagers who have trained in multiple modalities can provide those teams with a significant amount of value.
Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries
Safety concerns with certain Boston Scientific leads have resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August.
FDA clears AI-powered cardiac imaging platform
The Tempus Pixel platform was designed to assist clinicians with the evaluation of cardiac MR images.
Key trends in nuclear cardiology take center stage at ASNC 2025
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."

Optical imaging may be ‘game-changer’ for predicting heart attacks

The improved optical coherence tomography approach may help cardiologists distinguish life-threatening plaques from those that are less dangerous.

FDA clears Ultromics’ AI-based CV image analysis system

U.K.-based health tech firm Ultromics has secured 510(K) FDA clearance for its EchoGo Core image analysis system, the company announced Nov. 14.

Expanding CTA to more stroke patients improves outcomes

Adopting a “CTA-for-All” policy helped radiologists detect large vessel occlusion (LVO) and improved outcomes for patients with acute ischemic stroke, according to a recent study published in Stroke.

ISCHEMIA: Invasive therapy no better than meds for reducing CV events

People with severe but stable ischemic heart disease don’t benefit any more from invasive CV procedures than they do from optimal medical therapy and lifestyle changes alone, according to results from the highly anticipated ISCHEMIA trial.

‘CTA-for-All’ fast-tracks intervention, improves LVO detection in stroke patients

A “CTA-for-All” stroke imaging policy improved LVO detection, fast-tracked intervention and improved outcomes in a recent study of patients with acute ischemic stroke, researchers reported in Stroke.

New deep learning study brings automated CAC scoring ‘one step closer to clinical translation’

Coronary artery calcium scoring has proven to be more predictive of cardiovascular risk than any other biomarker, but quantifying scores via imaging remains a time-consuming and labor-intensive task.

Experts see big potential for deep learning in cardiac MRI

Radiologists from the Netherlands believe deep learning can significantly impact cardiac MRI analysis in the not so distant future, sharing their thoughts in a piece published in the American Journal of Roentgenology.

FDA clears 1st AI-assisted cardiac MRI software

California-based tech company HeartVista announced Oct. 29 it had received FDA clearance for its AI-assisted One Click cardiac MRI acquisition software.

Cardiac Imaging

Shockwave Medical launches new IVL catheter for challenging lesions in Europe

Multimodality imagers play a critical role in modern heart teams

Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries

FDA clears AI-powered cardiac imaging platform

Key trends in nuclear cardiology take center stage at ASNC 2025